We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Logical Therapeutics, Inc. (Pittsburgh, PA) has entered into a licensing and collaboration agreement with Medinox, Inc. (Carlsbad, CA) for a novel non-steroidal anti-inflammatory agent (NSAID), to be known as LT-NS001.
Technologies, Inc. announced that it has entered into an agreement to sell, for approximately $21 million, the 50,000 square foot facility containing its pilot manufacturing plant and current corporate headquarters ("Witmer Road Facility") located in Horsham, Pennsylvania, to a public real estate investment trust.
German chemicals and pharmaceuticals giant Bayer says it is still open to further acquisitions even though it was still in the process of integrating Berlin-based drug maker Schering which it recently acquired for close to 17 billion euros (22 billion dollars).
The Bush administration's point person for the Medicare and Medicaid health programs, Mark McClellan, is stepping down, the White House said on Tuesday.
Mylan Laboratories has announced it will acquire a major interest in India-based Matrix Laboratories for $736 million, a deal that will make the company a "global leader" in the generics industry, Mylan's top executive said.
A federal judge's decision to block further sales of Apotex's generic version of blockbuster blood-thinner Plavix makes it unlikely that the company will successfully challenge the patent at trial, Wall Street observers say.
Akorn, Inc. announced that it has signed a Commercial Manufacturing Supply Agreement with GeneraMedix Inc., a privately held pharmaceutical company that develops, markets and sells generic injectable pharmaceutical products.